Please login to the form below

Not currently logged in
Email:
Password:

Cello Health acquires market research firm Promedica

Move is the group’s second acquisition of the year
Cello Health logo

The healthcare communications group Cello Health continued its expansion with the acquisition of San Francisco-based market research consulting company Promedica.

Promedica, a specialist in new product planning for life science companies, is also an adviser to biotech, pharma, diagnostic firms, start-ups and the investment community.

Stephen Highley, Cello Health chairman, said: “This acquisition, and the introduction of Promedica's experienced and talented team into Cello Health, will enable us to open up capacity on the West Coast [of the US], where we are seeing significant activity and potential with both pharma and biotech clients.

“We are now very much focused on our expansion in the US through our three core capabilities in insight, consulting and communications, and the acquisition of Promedica fits with this strategy.”

Promedica will work closely with Cello Health's market research branch Cello Health Insight in London, New York and Chicago, alongside working with its US teams in consulting and communications.

The acquisition is Cello Group's second of the year, the first being that of iS Health Dynamics in May for £2.5m.

Joan Day, president of Promedica, added: “We are excited to join the Cello Health family and offer our clients the benefits of expanded capabilities and access to a broad and deep global network of healthcare expertise.”

The initial value of the deal is $700,000 in cash, with a maximum of $1.8m payable depedning on the financial performance of the business.

Article by
Kirstie Pickering

11th December 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics